Chapter 56. New Vaccine Technologies and the Control of Viral Hepatitis

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. Colin R Howard

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch56

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

Howard, C. R. (2005) New Vaccine Technologies and the Control of Viral Hepatitis, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch56

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131

SEARCH

Keywords:

  • vaccine technologies;
  • viral hepatitis;
  • DNA vaccination;
  • nucleic acid vaccines;
  • therapeutic vaccines

Summary

This chapter contains sections titled:

  • Can existing hepatitis B vaccines be improved upon?

  • Prospects for hepatitis C vaccines

  • Therapeutic vaccines

  • Conclusion: the vision